Fresenius traded at 28.53 this Tuesday July 5th, decreasing 0.79 or 2.69 percent since the previous trading session. Looking back, over the last four weeks, Fresenius lost 8.82 percent. Over the last 12 months, its price fell by 34.89 percent. Looking ahead, we forecast Fresenius to be priced at 28.10 by the end of this quarter and at 25.20 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
28.53
Daily Change
-2.69%
Yearly
-34.89%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Akzo Nobel 61.38 -1.34 -2.14% -40.49%
Alcon AG 67.84 -0.12 -0.18% 3.92%
AstraZeneca 10,800.00 -8.00 -0.07% 23.84%
BASF 39.33 -2.56 -6.11% -40.45%
Bayer 55.52 -1.72 -3.00% 9.55%
Beiersdorf 98.76 -0.44 -0.44% -4.58%
DSM 140.10 1.15 0.83% -11.86%
DaVita Healthcare Partners 82.07 -1.04 -1.25% -32.10%
Essilor 139.50 -0.30 -0.21% -7.98%
E.ON 7.92 -0.25 -3.11% -20.35%
Fresenius Medical Care 47.26 -0.40 -0.84% -30.19%
Fresenius Medical Care 24.59 -0.52 -2.07% -38.69%
Fresenius 28.53 -0.79 -2.69% -34.89%
Getinge 241.70 -0.60 -0.25% -25.19%
Givaudan 3,462.00 19.00 0.55% -19.75%
GN Store Nord 245.10 -5.60 -2.23% -57.00%
GRIFOLS 17.56 -0.28 -1.54% -21.61%
GlaxoSmithKline 1,786.60 -16.00 -0.89% 24.57%
Hikma Pharmaceutical 1,638.00 -16.00 -0.97% -35.94%
Lonza Group 529.60 4.80 0.91% -20.46%
Merck 167.85 2.45 1.48% 1.39%
Novartis 80.91 -0.74 -0.91% -4.31%
Philips 20.07 -0.08 -0.37% -50.12%
Roche Holding 319.00 -3.60 -1.12% -9.76%
RWE 35.49 -1.12 -3.06% 13.21%
Sanofi 97.12 -1.22 -1.24% 11.93%
Smith & Nephew PLC 1,130.00 -10.00 -0.88% -28.91%
William Demant Holding 269.40 1.20 0.45% -26.47%

Indexes Price Day Year
DE40 12401 -372.18 -2.91% -20.05%
EU50 3360 -92.59 -2.68% -17.10%

Fresenius
Fresenius SE & Co KGaA is a Germany-based healthcare group. It operates through four business segments. Fresenius Medical Care runs a global network of dialysis clinics, providing treatment for patients with chronic kidney failure. It also offers dialyzers, dialysis machines and renal pharmaceuticals. Fresenius Kabi specializes in intravenously administered generic drugs (IV drugs), clinical nutrition and infusion therapies. It also supplies hospitals with medical devices and products of transfusion technology. Fresenius Helios is a private hospital operator, with over 130 facilities in Germany, including maximum care hospitals and rehabilitation centers and, through Quironsalud, over 80 hospitals and outpatient centers, as well as approximately 300 Occupational Risk Prevention Centers in Spain. Fresenius Vamed manages projects and provides services for health care facilities worldwide, from development and turnkey construction to maintenance and total operational management.